Addison’s Disease Market Report 2032 | DelveInsight DelveInsight's "Addison’s Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Addison’s Disease, historical and forecasted epidemiology as well as the Addison’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Addison’s Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Addison’s Disease market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Addison’s Disease treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Addison’s Disease market.
Addison’s Disease: An Overview Addison's disease, also called adrenal insufficiency, is an uncommon disorder that occurs when your body doesn't produce enough of certain hormones. In Addison's disease, your adrenal glands, located just above your kidneys, produce too little cortisol and, often, too little aldosterone. Addison's disease occurs in all age groups and both sexes, and can be life-threatening. Treatment involves taking hormones to replace those that are missing.